Amarin Corporation plc (NASDAQ: AMRN) (Amarin), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today announced new data from a post hoc analysis of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results